Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2008-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2008.08.002PMID 18793858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.

  2008cited by this paper
• Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.

  2007cited by this paper
• Putative drug binding conformations of monoamine transporters.

  2006cited by this paper
• Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.

  2006cited by this paper
• Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.

  2005cited by this paper
• Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.

  2005cited by this paper
• Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.

  2005cited by this paper
• PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders.

  2005cited by this paper
• Synthesis of N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine as a serotonin transporter imaging agent.

  2003cited by this paper
• Molecular Mechanism of Citalopram and Cocaine Interactions with Neurotransmitter Transporters

  2003cited by this paper
• Pharmacological Characterization ofN,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity

  2003cited by this paper
• Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents.

  2003cited by this paper
• Positron emission tomography: imaging and quantification of neurotransporter availability.

  2002cited by this paper
• Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA).

  2002cited by this paper
• Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

  2002cited by this paper
• Substituted diphenyl sulfides as selective serotonin transporter ligands: synthesis and in vitro evaluation.

  2002cited by this paper
• New PET imaging agent for the serotonin transporter: [(18)F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thio]-N,N-dimethyl-benzenmethanamine).

  2002cited by this paper
• Molecular modeling of potential new and selective PET radiotracers for the serotonin transporter. Positron Emission Tomography.

  2002cited by this paper
• Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter

  2001cited by this paper
• Structure-activity relationship of analogs of adam as ligands for serotonin transporters

  2001cited by this paper
• Selective in vitro and in vivo binding of [125I]ADAM to serotonin transporters in rat brain

  2000cited by this paper
• 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.

  2000cited by this paper
• Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB

  2000cited by this paper
• Depression and Anxiety in Parkinson's Disease: Possible Effect of Genetic Variation in the Serotonin Transporter

  1999cited by this paper
• A general and fast scoring function for protein-ligand interactions: a simplified potential approach.

  1999cited by this paper
• Characterization of [123I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters

  1999cited by this paper
• A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.

  1999cited by this paper
• Role of the Serotonergic System in the Pathogenesis of Major Depression and Suicidal Behavior

  1999cited by this paper
• Radiosynthesis of carbon‐11 labelled N‐methyl‐2‐(arylthio)benzylamines: potential radiotracers for the serotonin reuptake receptor

  1999cited by this paper
• A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.

  1999cited by this paper
• The serotonin transporter and depression

  1998cited by this paper
• The spectrum of behaviors influenced by serotonin.

  1998cited by this paper
• Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

  1998cited by this paper
• Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs

  1998cited by this paper
• Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for σ-1 receptors : In vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine

  1997cited by this paper
• Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.

  1997cited by this paper
• The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

  1994cited by this paper
• [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET.

  1993cited by this paper
• [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. II. In vivo studies in rats.

  1993cited by this paper
• LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads

  1992cited by this paper
• The computer program LUDI: A new method for the de novo design of enzyme inhibitors

  1992cited by this paper
• Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT.

  1991cited by this paper
• Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.

  1987cited by this paper
• A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.

  1983cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Serotonin receptor imaging by 18F-PET

  2019cites this paper
• Discovery of Novel-Scaffold Monoamine Transporter Ligands via in Silico Screening with the S1 Pocket of the Serotonin Transporter

  2014cites this paper
• Fluorinated diaryl sulfides.

  2013cites this paper
• FlipADAM: a potential new SPECT imaging agent for the serotonin transporter.

  2010cites this paper
• Developing new molecular imaging probes for PET.

  2009cites this paper
• Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

  2009cites this paper
• Current awareness in contrast media and molecular imaging.

  2009cites this paper
• Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.

  2008cites this paper